Characterization of both myocardial extracellular volume expansion and myocyte hypertrophy by CMR in heart transplantation recipients without active rejection: implications for early cardiac remodeling

Coelho‐Filho, Otávio R.; Shah, Ravi; Neilan, Tomas G.; Souza, José Roberto Mattos; Júnior, Jose Carlos Barros; Lavagnoli, Carlos Fernando Ramos; Filho, Lindemberg da Mota Silveira; Oliveira, Pedro Paulo Martins de; Severino, Elaine Soraya Barbosa de Oliveira; Jerosch‐Herold, Michael; Petrucci, Orlando

doi:10.1186/1532-429x-17-s1-o75

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2018

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These include quantification of the intracellular lifetime of water (tau), a measure proportional to cardiomyocyte diameter and determination of the total cardiomyocyte LV mass. 71 However, while promising, these techniques are limited to specialized centers and data applying these techniques are pending.…”

Section: Introductionmentioning

confidence: 99%

Advanced imaging modalities to detect cardiotoxicity

Awadalla

Hassan

Alvi

et al. 2018

Current Problems in Cancer

View full text Add to dashboard Cite

Recent advances in cancer treatments have significantly improved survival rates, reemphasizing the focus on reducing the potential complications associated with some therapies. Cardiovascular disease associated with chemotherapies is a major cause of morbidity and mortality in cancer survivors. Early detection of cardiotoxicity improves cardiac outcomes among cancer patients. The review will focus on imaging modalities used to assess cardiotoxicity - the cardiovascular consequences of chemotherapies. The review will discuss the benefits and limitations associated with each technique, as well as the guidelines available to help identify at risk patients. We will discuss novel techniques that may help detect earlier signs of cardiotoxicity, directing management that may improve clinical outcomes.Published by Elsevier Inc.

show abstract

Section: Introductionmentioning

confidence: 99%